Jinxin Technology Cures Nasdaq Minimum Bid Price Deficiency
NAMI sits 20% above its 52-week low of $3.1.
Summary
Jinxin Technology regained compliance with Nasdaq's minimum bid price requirement after its ADS closing price held at or above $1.00 for 10 consecutive business days, closing the deficiency matter.
Key Events · Corporate Governance and Compliance · NAMI
-
Nasdaq Compliance Regained
Nasdaq confirmed that Jinxin regained compliance with the minimum bid price rule after the ADS closing price stayed at or above $1.00 for 10 consecutive business days from June 26 to July 10, 2026.
-
Deficiency Closed
The bid price deficiency matter, first flagged in January 2026, is now closed by Nasdaq, removing the immediate delisting threat.
-
Reverse Split Catalyst
The 1-for-25 reverse ADS split effective June 25, 2026, boosted the share price above the $1.00 threshold, enabling the compliance cure.
-
Listing Stability Restored
Maintaining the Nasdaq listing preserves access to capital markets and institutional investor eligibility, critical for the company's turnaround efforts.
Analysis · NAMI · Trade & Services
A critical listing threat has been resolved. Nasdaq notified Jinxin Technology that its ADS closing bid price remained at or above $1.00 for 10 consecutive business days—from June 26 through July 10, 2026—curing the minimum bid price deficiency. This removes the immediate delisting risk that had been hanging over the stock since January 2026. The catalyst was the 1-for-25 reverse split on June 25, 2026, and the subsequent price stability confirms the fix worked. For a micro-cap company facing recent financial distress and insider selling, maintaining the Nasdaq listing is essential for liquidity and investor confidence.
At the time of this filing, NAMI was trading at $3.72 on NASDAQ in the Trade & Services sector, with a market capitalization of approximately $10.8M. The 52-week trading range was $3.10 to $51.25. This filing was assessed with positive market sentiment and an importance score of 7 out of 10.